Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 45 (Search time: 0.005 seconds).

No. Year Title Type
45 2023

2023Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
44 2022

2022Report

화학유전체 기법을 활용한 전통천연약물 다중 표적 발굴 및 검증 = Multi-target discovery and validation of traditional medicines by chemical genomics연구책임자 : 한동초 / 주관부처 : 과학기술정보통신부한동초; 권병목; 이유진; 최지연; 윤선; 장현진
Report
43 2022

2022Article

S-benproperine, an active stereoisomer of benproperine, suppresses cancer migration and tumor metastasis by targeting ARPC2 = 벤프로페린의 활성 입체이성질체인 S-Benproperine은 ARPC2를 표적으로 하여 암세포 이동 및 종양 전이를 억제Pharmaceuticals, vol. 15, no. 12, pp. 1462-1462Hyun Jin Jang; Yae Jin Yoon; Jiyeon Choi; Yu-Jin LeeSangku Lee; W Cho; W G Byun; S B Park; Dong Cho Han; Byoung-Mog Kwon
Article
42 2022

2022Research Project

전임상 후보물질 VS-501의 기전규명 및 바이오마커 발굴연구책임자 : 한동초 / 사업기간 : 2022.02.01 ~ 2022.12.31
Research Project
41 2022

2022Research Project

바이오 빅데이터 기반 난치성 암 맞춤의약 원천기술 개발 = Bio big-data driven study for targeted therapy of currently untreatable cancers연구책임자 : 박경찬 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
40 2022

2022Research Project

화학유전체 기법을 활용한 전통천연약물 다중 표적 발굴 및 검증 = Muti-target discovery and validation of traditional medicines연구책임자 : 한동초 / 사업기간 : 2022.01.01 ~ 2022.08.31
Research Project
39 2021

2021Article

Targeting HSF1 as a therapeutic strategy for multiple mechanisms of EGFR inhibitor resistance in EGFR mutant non-small-cell lung cancer = 활성 EGFR 발현 비소세포 폐암의 EGFR 표적항암제에 대한 다중 내성 치료표적으로의 HSF1Cancers, vol. 13, no. 12, pp. 2987-2987Sangah Lee; JiYae Jung; Yu-Jin LeeSeon-Kyu KimJung Ae KimBo Kyung KimKyung Chan Park; Byoung-Mog Kwon; Dong Cho Han
Article
38 2021

2021Article

8-Epi-xanthatin induces the apoptosis of DU145 prostate carcinoma cells through signal transducer and activator of transcription 3 inhibition and reactive oxygen species generationPhytotherapy Research, vol. 35, pp. 1508-1520Yujin Lee; Jiyeon Choi; Yae Jin Yoon; Yugyeong Sim; Hyung Won RyuSei-Ryang OhDoo-Young Kim; Jihyun Hwang; Seung-Wook ChiDong Cho Han, et al.
Article
37 2021

2021Article

Acacetin inhibits the growth of STAT3-activated DU145 prostate cancer cells by directly binding to signal transducer and activator of transcription 3 (STAT3)Molecules, vol. 26, no. 20, pp. 6204-6204Sun Yun; Yujin Lee; Jiyeon Choi; Byoung-Mog Kwon; Dong Cho Han
Article
36 2021

2021Research Project

신규 유전자가위 기반 유전자치료 원천기술 개발 = Development of gene therapy through a new genome editing technology연구책임자 : 고정헌 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
35 2021

2021Research Project

화학유전체 기법을 활용한 전통천연약물 다중 표적 발굴 및 검증 = Muti-target discovery and validation of traditional medicines연구책임자 : 권병목 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
34 2021

2021Research Project

ARPC2를 표적으로 하는 항암 및 암전이 억제제 개발 = Development of ARPC2 inhibitor for Anti-tumor and -metastasis agent연구책임자 : 권병목 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
33 2020

2020Article

Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells = 기존 약물인 Ethacrynic acid의 항암 효과 관련 표적 발굴 및 검증Biochemical Pharmacology, vol. 175, pp. 113920-113920Yu Jin Lee; Harim Song; Yae Jin Yoon; Seung Jin Park; Seon-Young KimDong Cho Han; Byoung-Mog Kwon
Article
32 2020

2020Research Project

신규 유전자가위 기반 유전자치료 원천기술 개발 = Development of gene therapy through a new genome editing technology연구책임자 : 고정헌 / 사업기간 : 2020.01.01 ~ 2020.12.31
Research Project
31 2020

2020Research Project

화학유전체 기법을 활용한 전통천연약물 다중 표적 발굴 및 검증 = Muti-target discovery and validation of traditional medicines연구책임자 : 권병목 / 사업기간 : 2020.01.01 ~ 2020.12.31
Research Project
30 2020

2020Research Project

세포신호전달 단백질의 기능을 조절하는 선도물질 개발 = Discovery of lead molecules for modulation of cellular signalling proteins연구책임자 : 권병목 / 사업기간 : 2020.01.01 ~ 2020.05.31
Research Project
29 2020

2020Research Project

ARPC2를 표적으로 하는 항암 및 암전이 억제제 개발 = Development of ARPC2 inhibitor for Anti-tumor and -metastasis agent연구책임자 : 권병목 / 사업기간 : 2020.03.01 ~ 2020.12.31
Research Project
28 2019

2019Article

2'-Hydroxycinnamaldehyde inhibits proliferation and induces apoptosis via signal transducer and activator of transcription 3 inactivation and reactive oxygen species generation = 2’-Hydroxycinnamaldehyde는 STAT3와 ROS의 활성 조절을 통해 항암 효과Cancer Science, vol. 110, pp. 366-378Yae Jin Yoon; Young Hwan Kim; Yu Jin Lee; Jiyeon Choi; C H Kim; Dong Cho Han; Byoung-Mog Kwon
Article
27 2019

2019Article

Benproperine, an ARPC2 inhibitor, suppresses cancer cell migration and tumor metastasis = ARPC2 저해제인 벤프로페린의 암 전이 효과Biochemical Pharmacology, vol. 163, no. 1, pp. 46-59Yae Jin Yoon; Young-Min Han; Jiyeon Choi; Yu Jin Lee; Jieun Yun; Su-Kyung Lee; Chang Woo LeeJong Soon KangSeung-Wook ChiJeong Hee Moon, et al.
Article
26 2019

2019Article

Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complexCancer Science, vol. 110, no. 12, pp. 3788-3801Jiyeon Choi; Yu Jin Lee; Yae Jin Yoon; C H Kim; Seung Jin Park; Seon-Young Kim; N D Kim; Dong Cho Han; Byoung-Mog Kwon
Article
1 2 3